1. Home
  2. Directory
  3. North Carolina
  4. Fayetteville
  5. Radiology
  6. NPI Profile
  7. Prescriptions 1447547567

DR. ABHIJEET R BHIRUD M.D.
Prescription History 1447547567
Radiology - Radiation Oncology in Fayetteville, NC


Quality Rating: 75 out of 100 score

NPI Status: Active since July 10, 2011

Contact Information

1638 OWEN DR
FAYETTEVILLE, NC
ZIP 28304
Phone: (910) 615-6691
Fax: (910) 615-5398

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ABHIJEET R BHIRUD M.D., an active Radiation Oncology specialist practicing in Fayetteville, NC. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 46 documented patient claims. Among these therapy options, the most frequently utilized medication is Orgovyx, which accounts for 23 claims alone.

Medication Index

O
No matching medications currently found on file.

Orgovyx

Generic Formulation: RelugolixSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 23
30-Day Fills 23.0
Days Supply 686
NC State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills35.7
Peer Average Days Supply1,067
Conservative Utilization

This provider writes prescriptions for this formulation 34.3% less frequently than the standard regional baseline metric for practitioners inside NC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $61,959.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,693.91

State Avg Cost Per Claim

$2,625.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Relugolix is used to treat prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Relugolix works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 128
NC State Average Benchmarks
Peer Average Claims69.0
Peer Average 30-Day Fills69.2
Peer Average Days Supply1,512
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.1% less volume than the regional standard for practitioners inside NC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $229.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.83

State Avg Cost Per Claim

$26.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 89
NC State Average Benchmarks
Peer Average Claims91.0
Peer Average 30-Day Fills91.5
Peer Average Days Supply2,294
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.8% less volume than the regional standard for practitioners inside NC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $170.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.17

State Avg Cost Per Claim

$49.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. ABHIJEET R BHIRUD M.D. provides transparency into local medical care patterns within Fayetteville, NC.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Radiation Oncology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.